Sarepta Therapeutics Announces Ian Estepan Named President And Chief Operating Officer; Ryan Wong, Named Chief Financial Officer

+3.53% Pre

Sarepta Therapeutics, Inc.

SRPT

22.31

22.44

+3.53%

+0.58% Pre

Executive Leadership Appointments

In conjunction with the restructuring, Sarepta announced key executive appointments:

Ian Estepan named President and Chief Operating Officer
Louise Rodino-Klapac, Ph.D., named President of Research & Development and Technical Operations
Ryan Wong, named Chief Financial Officer, previously Senior Vice President of Strategic Finance, Treasury, and Investor Relations
Rachael Potter, Ph.D., named Chief Scientific Officer, previously Senior Vice President, Head of Research Sciences
Patrick Moss, Pharm.D., named Chief Commercial Officer, previously Senior Vice President of U.S. Market Access and Sales, succeeding Dallan Murray, Chief Customer Officer, who is leaving Sarepta. The Company thanks Mr. Murray for his long-time service and wishes him well.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.